The questionnaire was sent to 26 countries; 11 of these countries had reported outbreaks of LGV in the past. Completed questionnaires were received from 18 countries (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Scotland, Slovenia, Spain, Sweden, Switzerland, United Kingdom, and Turkey). Of the 18 questionnaires, 12 were completed by medical doctors, 4 by medical epidemiologists, and 2 by researchers/microbiologists. In 5 countries (Belgium, Ireland, Portugal, Slovenia, and Sweden), the questionnaire was fi lled in by 2 or more experts from different areas of expertise. The 8 countries that did not respond to either the questionnaire or the electronic reminders (Slovak Republic, Poland, Malta, Latvia, Iceland, Cyprus, Estonia, and Greece) were excluded from the analysis. A complete overview of the activities reported for controlling LGV and their development and implementation is given in the Tables 1 and 2 . 